NASDAQ:KMPH
Delisted
KemPharm Stock News
$5.81
+0 (+0%)
At Close: May 26, 2023
KemPharm's KP415 and Serdexmethylphenidate (SDX) Prodrug to be Featured in Multiple Sessions at the 2021 APSARD Virtual Conference
07:30am, Thursday, 14'th Jan 2021
Combination of Oral and Poster Presentations Scheduled for January 15, 2021
KemPharm Participating in BIO @ JPM and Fierce JPM Week 2021 Virtual Events During “J.P. Morgan Week 2021”
07:30am, Wednesday, 13'th Jan 2021
CELEBRATION, Fla., Jan. 13, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced
Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “KMPH” today, January 8, 2021
KemPharm Announces 1-for-16 Reverse Stock Split
06:11pm, Wednesday, 23'rd Dec 2020
CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
07:30am, Tuesday, 22'nd Dec 2020
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced
KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
07:30am, Wednesday, 02'nd Dec 2020
CELEBRATION, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced
REMINDER: KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
07:30am, Monday, 30'th Nov 2020
Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ET
KemPharm Provides Update on Development Pipeline
04:30pm, Monday, 23'rd Nov 2020
IND for KP879 Expected to be Filed Before Year-End 2020; New Prodrug Candidate Added to Pipeline , Targeting Rare CNS Disease , Idiopathic Hypersomnia (IH)
KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
08:30am, Wednesday, 18'th Nov 2020
Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ET
KemPharm Reports Third Quarter 2020 Financial Results
04:05pm, Thursday, 29'th Oct 2020
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4 : 3 0 p.m. ET
KemPharm Postpones Special Meeting of Stockholders, Announces Date for Q3 2020 Results Call
08:30am, Monday, 26'th Oct 2020
Special Meeting of Stockholders Rescheduled to Tues day , Nov 17, 2020, 8:00 a.m. ET
